Observational studyInternal medicine (Tokyo, Japan)2021

Impact of the Concomitant Use of Immunomodulator and a Lower Week 8 Partial Mayo Score on the Persistence of Adalimumab in Refractory Ulcerative Colitis.

Shinsuke Kumei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.